Weconductedastudytovalidate theexpression ofPLUNC (palate, lung, and nasalepithelial clone) protein in nasal polypandchronic sinusitis tissue byimmunohistochemistry. Wealso explored therelationship between theintensity of positive immunohistochemical staining for PLUNC protein andpostoperative therapeutic efficacy. Ourstudy population consisted of34 patientswith nasalpolyps and 30 with chronic sinusitis who had undergone surgical treatment , along with 18 healthy controls who did not undergo surgery. Allsamples were stainedaccording tothe streptavidin-peroxidase immunohistochemical methodto examinePLUNCprotein expression. The surgicalpatients were evaluated for clinical therapeutic efficacy6 months postoperatively. The association between efficacy and the intensit y of PLUNC protein positivity was examined by the Spearman rank correlation analysis. Intensity was rated as either+++ (>50%positive cells), ++ (26 to 50% positive cells), + (~25 % positive cells), or -(no positive cells). Wefound that the most common levels of PLUNC positivity were + in thepatientswith nasalpolyps, +++ in thepatientswith chronicsinusitis, and ++ in the controls (p < 0.01). Analysis of the Spearman rank correlation indicated that the intensit y of PLUNC protein expression wassignificantly correlatedwithpostoperative therapeutic efficacy (p < 0.001). Weconclude that PLUNC protein is 282 • www.entjournal.com an essential factor in the innate defense mechanism of the nasal mucosa. The immunohistochemical staining of PLUNC protein couldhaveclinical benefit in terms of predicting therapeutic efficacy and outcomes in patients with nasal polyps or chronic sinusitis.
Introduction
From 2004 to 2006, we performed pH 3-10 and pH 4-7 gradient two-dimensional electrophoresis (2-DE) on tissue samples of nasal polyps, chronic sinusitis, and normal nasal mucosa. Wefound that some proteins were differentially expressed in these tissues. In pH 4-7 gradient 2-DE, various antimicrobial proteins-including PLUNC (palate, lung, and nasal epithelial clone), SOD, NKEF-B,PACAP, glutathione S-transferase pi, and DJ-l proteins-were highly expressed in chronic sinusitis but expressed at low levels in nasal polyps. ' We selected the novel secretory PLUNC protein for immunohistochemical analysis in paraffin-embedded tissue samples to validate the differential expression among nasal polyps, chronic sinusitis, and normal nasal mucosal tissue, and to observe the localization of its expression in tissues and cells. The protein must be validated repeatedly to ensure reliable and stable results . Furthermore, proteins showing differential expression only correlated with clinical therapeutic efficacy may be of clinical value.
Patients and methods
We conducted ongoing follow-up observations of 64 patients who had undergone functional endoscopic sinus surgery to treat either nasal polyps (n =34) or chronic sinusitis (n = 30). The 34 patients with nasal polyps included 19 men and 15 women, aged 18 to 54 years (mean: 40), and the 30 patients with chronic sinusitis included 16 men and 14 women, aged 22 to 58 years (mean: 41).
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Paraffin-embedded tissue samples were obtained from the 34 patients who had had nasal polyps and the 30 patients who had had chronic sinusitis , as well as from the nasal mucosa of 18 normal controls; the control group was made up of 10 men and 8 women, aged 16 to 30 years (mean: 21). The nasal polyp and sinusitis tissues were obtained from the ethmoid sinus in the 64 patients. For control purposes, normal mucosal tissue was obtained from the middle turbinates of patients with a simple deviated nasal septum. The nasal polyp tissue was clearly different from the chronic sinusitis tissue as seen during the preoperative nasal endoscopic examination, on computed tomography (CT), and at the final pathologic diagnosis.
None of the patients had allergic rhinitis, aspirin intolerance triad, asthma, or ciliary dyskinesia, and none had used a corticosteroid or antibiotic during the 2 weeks before their operation. All of the samples had been confirmed as nasal polyps, chronic sinusitis, or normal nasal mucosa by pathologic diagnosis.
To ascertain the intensity of PLUNC protein expression, we cut the paraffin -embedded tissue blocks into 4-llm-thick sections , which were then deparaffinized, dehydrated through a graded alcohol series, rehydrated, and subjected to antigen recovery by autoclaving. All samples were then stained using the streptavidinperoxidase immunohistochemical method (Maxim Biotech; Rockville, Md.).
After nonspecific binding sites were blocked with 0.3% HP2 in methanol for 30 minutes, the sections were incubated with normal nonimmune serum for 1 hour. The sections were then incubated for 30 minutes with goat polyclonal antibody against PLUNC protein (1:200 dilution; R&D Systems, Minneapolis), followed by a biotin-conjugated secondary antibody (Maxim Biotech) for 10 minutes. The sections were then colorized with diaminobenzidine/hydrogen peroxide and counterstained with Harris modified hematoxylin. For control analyses, the primary antibody was replaced by phosphate-buffered saline. Finally, the sections were examined under a BX60microscope (Olympus ;Tokyo).
The intensityofPLUNC protein positivity was rated as either +++(>50%positive cells), ++ (26 to 50%positive cells), + (S25% positive cells), or -(no positive cells). Statistical analyses were performed using the chi-square in China. Therapeutic efficacy was classified into two categories, recurrence and no recurrence, which were defined thus:
• Recurrence: Patients had undergone no lessthan two functional endoscopic sinus surgeries or symptoms were not relieved; the nasal mucosa showed adherence; the paranasal sinus ostia showed stenosis or atresia; nasal polyps recurred with purulent secretions as determined by nasal endoscopy.
• No recurrence: Symptoms resolved or decreased; the paranasal sinus ostia were open; epithelialization of the nasal mucosa occurred with little or no purulent secretions as determined by nasal endoscopy.
Next, we examined the correlation between clinical efficacy and the intensity of immunohistochemical positivity for PLUNC protein using the Spearman rank correlation analysis.
Our study protocol was approved by ethics committee of the Xiangya Hospital of Central South University in Changsha, China.
Results
Immunohistochemistry revealed that the PLUNCpositive cells were mainly expressed in nasal mucosa epithelium, in goblet cells, and especially in glandular epithelium. In addition, these cells exhibited a brown color in the cytoplasm and glandular organ lumina. The most common levelsof intensity ofPLUNC protein expression were +in the nasal polyp samples, +++in the chronic sinusitis samples, and ++ in the normal nasal mucosal tissue ( figure, table 1 ). The differences in the degree ofpositivity ofPLUNC protein expression among the three kinds of tissue were statistically significant (X 2 = 28.834;p < 0.01).
Analysis of the Spearman rank correlation indicated that the intensity of PLUNC protein expression was significantly correlated with postoperative therapeutic efficacy (correlation coefficient = 0.702; p < 0.001 [2-tailedJ) . Patients whose intensity ofPLUNC protein positivity was +++ or ++ were categorized in the no recurrence group, while those whose PLUNC protein intensity was + or -were categorized in the recurrence group (table 2) .
Discussion
Using pH 4-7 gradient 2-DE, we found that the novel secretory protein PLUNC is differentially expressed among nasal polyps, chronic sinusitis, and normal nasal ' Sung et al detected upregulation of PLUNC protein expression after bulbectomy in the respiratory epithelium and suggested that PLUNC protein may provide protection against infection after injury. 6 Bingle and Gorr suggested that PLUNC protein may playa role in the innate immune response of the upper airways.'
In our study,both proteomics and immunohistochemical analyses indicated thatthe highest levelsofPLUNC protein expression occurred in chronicsinusitis and the lowest levels in nasal polyps. Our immunohistochemical analyses demonstrated that PLUNC-positive cells were mainly present in nasal mucosal epithelium, in goblet cells, and particularly in glandular epithelium. In addition, PLUNC-positive cells showed a brown color in the cytoplasm and glandular organ lumina, confirming that it is a secretory protein. 8,9 ' These observations suggest that in response to irritation by infectious agents or chemical factors, the nasal mucosal epithelium, goblet cells, and glandular epithelium will proliferate reactively and produce anti-inflammatory agents, including PLUNC protein, as a defense against Total Positivity the irritant.
(n)
Recent studies have detected the expression of antimicrobial proteins-such as lysozymes, lactoferrin, secretory IgA, defensins, and Toll-like receptors-in the respiratory mucosal epithelium, goblet cells,and glandular epithelium. These molecules are important components of the respiratory mucosal immune defense system, as well as the respiratory mucus cilia transmission system.":" On irritation ofthe respiratory mucosa by infectious agents or chemical factors, production of such anti-inflammatory agents are upregulated as a defense mechanism. This indicates that inflammation is essentially a defensive reaction against irritants. PLUNC protein isalso an im- In our study of 64 patients who had undergone functional endoscopic sinus surgery to treat nasal polyps or chronic sinusitis, statistical analysis indicated that the intensity of PLUNC protein expression was significantly correlated with postoperative therapeutic efficacy (p < 0.001). Our results suggest, therefore, that the immunohistochemical staining of PLUNC protein could have clinical benefit for predicting prognosis and therapeutic efficacy in patients with chronic sinusitis and nasal polyps.
Therapeutic efficacyis generally accepted to be poorer in patients with nasal polyps or chronic sinusitis whose affected tissue contains large numbers of eosinophils and elevated levels of leukotrienes and IgE. In our study, we found that therapeutic efficacy was poorer in patients whose levels ofPLUNC protein in affected tissue were lower. Therefore, it stands to reason that these objective indices can be used to determine prognosis and therapeutic efficacy. Certainly our findings should encourage further study oflarger samples. For our own future studies, we will use high-throughput experimental techniques such as proteomics and microarray analyses to identify additional objective ind ices for quantitatively monitoring the progression of disease states and responses to therapy.
